The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Genocea Biosciences, Inc.

NEW YORK--()--The Klein Law Firm announces the commencement of an investigation of Genocea Biosciences, Inc. (NASDAQ:GNCA) concerning possible violations of federal securities laws.

On September 25, 2017, Genocea disclosed that it was halting spending and activities on GEN-003 and exploring strategic alternatives for the drug. The Company also announced that it was cutting 40% of its workforce.

If you suffered a loss in Genocea and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kkclasslaw.com/GNCA-Info-Request-Form-219.

Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

The Klein Law Firm
Joseph Klein, Esq., 212-616-4899
Fax: 347-558-9665
www.kleinstocklaw.com

Release Summary

The Klein Law Firm notifies investors of the commencement of an investigation of Genocea Biosciences, Inc.

Contacts

The Klein Law Firm
Joseph Klein, Esq., 212-616-4899
Fax: 347-558-9665
www.kleinstocklaw.com